Get ready for a wild UCAAMP lunch with the Zoo
Join UCAAMP for lunch along with Thane Maynard and his animal friends from the Cincinnati Zoo
Event Information (passed)
Join UCAAMP from 11:30 a.m. to 1 p.m. on Monday, March 18, for lunch, networking, and an update from the zoo along with animal appearances.
Thane Maynard, director of the Cincinnati Zoo and Botanical Gardens, will discuss updates and what is happening around the zoo. Guests will also have the opportunity to pet and interact with a penguin and Lucy the bearcat. Dress like a penguin by wearing white and black or show your Bearcat spirit with your best UC gear.
Menu
- Caesar salad
- Oven braised chili rubbed beef brisket and savory tomato sauce
- Artisan banquettes
- Garlic mashed potatoes
- Seasoned asparagus
- Cheesecake and strawberry sauce
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.